This study confirms the bidirectional regulation between CHIP and PDE9A, which mediate cGMP/cAMP signal crosstalk and could become a common therapeutic direction for these NDDs, making PDE9A and CHIP a promising strategy for exploring NDD therapeutics. Here, PDE9A is linked to Neurodevelopmental delay.